Mutual of America Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.38M Sell
59,483
-2,417
-4% -$202K 0.05% 411
2026
Q1
$4.96M Sell
61,900
-573
-0.9% -$47.2K 0.06% 399
2025
Q4
$5.33M Sell
62,473
-1,313
-2% -$108K 0.06% 411
2025
Q3
$4.96M Sell
63,786
-3,615
-5% -$282K 0.05% 445
2025
Q2
$5.27M Sell
67,401
-1,338
-2% -$99.8K 0.06% 418
2025
Q1
$4.98M Sell
68,739
-2,072
-3% -$148K 0.06% 424
2024
Q4
$5.24M Sell
70,811
-3,535
-5% -$247K 0.06% 421
2024
Q3
$4.91M Sell
74,346
-1,816
-2% -$132K 0.05% 469
2024
Q2
$7.04M Sell
76,162
-3,539
-4% -$313K 0.08% 284
2024
Q1
$7.62M Sell
79,701
-1,654
-2% -$139K 0.08% 266
2023
Q4
$6.2M Sell
81,355
-14,231
-15% -$990K 0.07% 328
2023
Q3
$6.62M Buy
95,586
+8,189
+9% +$658K 0.08% 254
2023
Q2
$8.24M Sell
87,397
-1,258
-1% -$109K 0.09% 217
2023
Q1
$7.33M Buy
88,655
+138
+0.2% +$10.8K 0.09% 253
2022
Q4
$6.6M Buy
88,517
+2,502
+3% +$193K 0.08% 309
2022
Q3
$7.11M Buy
86,015
+1,064
+1% +$102K 0.1% 238
2022
Q2
$8.08M Buy
84,951
+1,481
+2% +$153K 0.1% 214
2022
Q1
$9.83M Buy
83,470
+879
+1% +$98.6K 0.1% 205
2021
Q4
$10.7M Buy
82,591
+678
+0.8% +$79.1K 0.11% 203
2021
Q3
$9.27M Buy
81,913
+701
+0.9% +$80K 0.09% 226
2021
Q2
$8.41M Buy
81,212
+631
+0.8% +$59.5K 0.08% 278
2021
Q1
$6.74M Buy
80,581
+2,229
+3% +$188K 0.07% 351
2020
Q4
$7.15M Sell
78,352
-2,487
-3% -$206K 0.08% 300
2020
Q3
$6.45M Sell
80,839
-2,620
-3% -$204K 0.09% 259
2020
Q2
$5.77M Sell
83,459
-1,831
-2% -$130K 0.08% 285
2020
Q1
$5.36M Buy
85,290
+1,440
+2% +$104K 0.09% 262
2019
Q4
$6.52M Buy
83,850
+183
+0.2% +$14.3K 0.08% 308
2019
Q3
$6.13M Sell
83,667
-10,761
-11% -$756K 0.09% 298
2019
Q2
$5.82M Sell
94,428
-10,878
-10% -$658K 0.08% 314
2019
Q1
$6.72M Sell
105,306
-2,796
-3% -$160K 0.1% 249
2018
Q4
$5.52M Sell
108,102
-4,977
-4% -$252K 0.09% 283
2018
Q3
$6.56M Sell
113,079
-906
-0.8% -$44.3K 0.09% 277
2018
Q2
$5.53M Buy
113,985
+4,650
+4% +$217K 0.08% 329
2018
Q1
$5.08M Sell
109,335
-1,497
-1% -$65K 0.08% 361
2017
Q4
$4.16M Buy
110,832
+25,263
+30% +$927K 0.06% 496
2017
Q3
$3.12M Sell
85,569
-1,041
-1% -$39.7K 0.05% 615
2017
Q2
$3.41M Sell
86,610
-1,404
-2% -$51.2K 0.06% 550
2017
Q1
$2.76M Buy
88,014
+8,199
+10% +$257K 0.05% 656
2016
Q4
$2.49M Buy
79,815
+7,551
+10% +$245K 0.05% 674
2016
Q3
$2.9M Sell
72,264
-1,674
-2% -$63K 0.06% 556
2016
Q2
$2.46M Buy
73,938
+2,520
+4% +$86.2K 0.05% 597
2016
Q1
$2.1M Sell
71,418
-354
-0.5% -$9.77K 0.05% 643
2015
Q4
$1.89M Sell
71,772
-138
-0.2% -$3.58K 0.04% 705
2015
Q3
$1.7M Buy
71,910
+1,458
+2% +$35.2K 0.04% 736
2015
Q2
$1.67M Sell
70,452
-1,110
-2% -$25.1K 0.04% 796
2015
Q1
$1.7M Buy
71,562
+2,670
+4% +$59.9K 0.04% 786
2014
Q4
$1.46M Buy
68,892
+1,194
+2% +$24K 0.03% 845
2014
Q3
$1.15M Buy
67,698
+960
+1% +$15.2K 0.03% 927
2014
Q2
$955K Sell
66,738
-3,594
-5% -$48.7K 0.02% 1018
2014
Q1
$869K Sell
70,332
-84
-0.1% -$969 0.02% 1024
2013
Q4
$772K Sell
70,416
-2,682
-4% -$30.2K 0.02% 1043
2013
Q3
$848K Buy
73,098
+3,234
+5% +$37.8K 0.02% 978
2013
Q2
$782K Buy
+69,864
New +$827K 0.02% 967

Other funds holding EW

Mutual of America Capital Management's EW Position: Q2 2026 in Review

Mutual of America Capital Management reduced its Edwards Lifesciences (EW) stake by 3.9% in Q2 2026, selling an estimated $202K and leaving 59,483 shares worth $5.38M. The position accounts for 0.05% of the portfolio, ranked #411.

Mutual of America Capital Management first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.7M in Q4 2021. 1,051 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Mutual of America Capital Management held 59,483 shares of Edwards Lifesciences worth $5.38M as of Q2 2026.
  • Mutual of America Capital Management sold 2,417 Edwards Lifesciences shares in Q2 2026, an estimated $202K.
  • Edwards Lifesciences made up 0.05% of Mutual of America Capital Management's portfolio in Q2 2026, its #411 holding.
  • Mutual of America Capital Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
  • Mutual of America Capital Management's Edwards Lifesciences position peaked at $10.7M in Q4 2021.
  • 1,051 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.